Riding the metal wave: A review of the latest developments in metal-based anticancer agents
Metal-based complexes have demonstrated significant anticancer effects and have emerged
as candidates with great potential for cancer therapy. These agents are effective in a variety …
as candidates with great potential for cancer therapy. These agents are effective in a variety …
Recent Advances in Mitochondria‐Localized Luminescent Ruthenium (II) Metallodrugs as Anticancer Agents
Presently, the most effective way to transport drugs specifically to mitochondria inside the
cells is of pharmacophoric interest, as mitochondria are recognized as one of the most …
cells is of pharmacophoric interest, as mitochondria are recognized as one of the most …
Anticancer profile of coumarin 6-based Ir (iii) photocatalysts under normoxia and hypoxia by ROS generation and NADH oxidation
Herein, we have designed, synthesized, and characterized two novel coumarin-6-based Ir
(III) photo-catalysts viz.[Ir (CO6) 2 (dppz)] Cl (Ir1) and [Ir (CO6) 2 (aip)] Cl (Ir2), where CO6 …
(III) photo-catalysts viz.[Ir (CO6) 2 (dppz)] Cl (Ir1) and [Ir (CO6) 2 (aip)] Cl (Ir2), where CO6 …
LVVO-Ethyl Maltol-Based Metallodrugs (L2– = Tridentate ONO Ligands): Hydrophobicity, Hydrolytic Stability, and Cytotoxicity via ROS-Mediated Apoptosis
Four new oxidovanadium [VVOL1–4 (ema)] complexes (1–4) have been synthesized using
tridentate binegative ONO donor ligands H2L1–4 [H2L1:(E)-N′-(2-hydroxybenzylidene) …
tridentate binegative ONO donor ligands H2L1–4 [H2L1:(E)-N′-(2-hydroxybenzylidene) …
Fluorescent Diorganotin (IV) Complexes as Anticancer Agents: Study of Cytotoxicity, Cellular Localization, and Mechanism of Cell Death
Three luminescent mixed ligand diorganotin (IV) complexes [Sn2Ph4 (L) 1–3 (DPA)(MeOH)
Cl](where L1=(Z)-N-((E)-3-ethoxy-2-hydroxybenzylidene) isonicotinohydrazonic acid, L2=(Z) …
Cl](where L1=(Z)-N-((E)-3-ethoxy-2-hydroxybenzylidene) isonicotinohydrazonic acid, L2=(Z) …
Antitumor studies evaluation of triphenylphosphine ruthenium complexes with 5, 7-dihalo-substituted-8-quinolinoline targeting mitophagy pathways
ZF Wang, XQ Huang, RC Wu, Y ** new anticancer agents can be useful, with the ability to diagnose and treat
cancer worldwide. Previously, we focused on examining the effects of nonoxidovanadium …
cancer worldwide. Previously, we focused on examining the effects of nonoxidovanadium …
Hydrolytically Stable TiIV–Hydrazone-Based Metallodrugs: Protein Interaction and Anticancer Potential
In this work, three titanium (IV)[TiIV (L1–3) 2](1–3) complexes have been reported using
three different tridentate dibasic ONO donor hydrazone ligands, pyridine-4-carboxylic acid (3 …
three different tridentate dibasic ONO donor hydrazone ligands, pyridine-4-carboxylic acid (3 …
A Series of Non-Oxido VIV Complexes of Dibasic ONS Donor Ligands: Solution Stability, Chemical Transformations, Protein Interactions, and Antiproliferative Activity
A series of mononuclear non-oxido vanadium (IV) complexes,[VIV (L1–4) 2](1–4), featuring
tridentate bi-negative ONS chelating S-alkyl/aryl-substituted dithiocarbazate ligands H2L1 …
tridentate bi-negative ONS chelating S-alkyl/aryl-substituted dithiocarbazate ligands H2L1 …
A phenoxy-bridged trinuclear Ni (II) complex: synthesis, structural elucidation and molecular docking with viral proteins
A novel phenoxy-bridged trinuclear nickel (II) complex [Ni3 (μ-L) 2 (bipy) 3](1)(where
H3L=(E)-2-hydroxy-N-(2-hydroxy-3, 5-diiodophenyl)-3, 5-diiodobenzohydrazonic acid, bipy …
H3L=(E)-2-hydroxy-N-(2-hydroxy-3, 5-diiodophenyl)-3, 5-diiodobenzohydrazonic acid, bipy …